関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
変形成長因子β受容体II型における変異は,家族性胸前大動脈動脈瘤および解剖を引き起こす
Hariyadarshi Pannu1, Van Tran Fadulu, Jessica Chang
1Department of Internal Medicine, Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.
Circulation
|July 20, 2005
まとめ
変形成長因子ベータ受容体II型 (TGFBR2) 遺伝子の生殖系変異は,遺伝性胸前大動脈瘤および解剖 (TAAD) と関連しています. これらのTGFBR2変異は,特に460位では,家族性TAADの重要な原因です.
科学分野:
- 遺伝学 遺伝学とは
- 心血管医学は,心臓血管医学である.
- 分子生物学は分子生物学である.
背景:
- 家族性胸大動脈動脈瘤と解剖 (TAAD) は,遺伝的基礎を持ち,自己相性支配的なパターンで受け継がれます.
- 以前の研究では,家族性TAADに関連した染色体位置が特定されました.
- 成長因子ベータ受容体II型 (TGFBR2) を変容させる遺伝子は,調査の候補でした.
研究 の 目的:
- 家族性TAADの原因としてTGFBR2遺伝子の変異を調査する.
- 特定された突然変異がTAADに対する遺伝的傾向に起因するかどうかを判断する.
主な方法:
- TGFBR2遺伝子の8つのコードエクソンをすべて配列化しました.
- 関連のない80件の家族的なTAAD症例からのゲノムDNAの分析.
- TGFBR2セリン/スレオニンキナーゼドメインの構造分析.
主要な成果:
- TGFBR2変異は,家族的なTAADを持つ4つの無縁の家族で特定されました.
- すべての変異は,細胞内領域の位置460 (R460) のアルギニンに影響を与え,変異ホットスポットを示唆した.
- 変異は,TGFBR2信号伝達に干渉すると予測されています.
結論:
- ゲルムラインTGFBR2変異は,家族性TAADへの遺伝的傾向の5%を占めています.
- TGFBR2変異は,家族性TAADの重要な原因である.
- この発見は,TAADの病理生理学におけるTGF-β信号伝達の役割を強調しています.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K